... long and the results or side effects
Always best to consult with your doctor but I'll send you q link that shows controlled study by Bristol Meyers Squibb. Hope this helps. http://www.nejm.org/doi/full/10.1056/NEJMoa1107039
Unfortunately Apixaban is not approved for any use in the US. As of last month the FDA has stated they will make a decision on Apixaban by March 17, 2013. It is approved in the EU.
Sorry, but I can't give you any feedback on Xarelto. I'm sure you are aware that Xarelto was demonstrated non-inferior to warfarin for the primary composite endpoint of time to first occurrence of stroke (any type) or non-CNS systemic embolism, but superiority to warfarin was not demonstrated. This appears to be giving the doctors pause on prescribing it for this indication and therefore there has not been a lot of feedback in our area.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 4 Jun 2014 • 3 answers
Posted 20 Nov 2014 • 2 answers
Posted 26 Jul 2015 • 1 answer
Posted 29 Jul 2015 • 1 answer
Posted 4 Nov 2017 • 1 answer